Year 2020 / Volume 112 / Number 9
Original
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA study

675-681

DOI: 10.17235/reed.2020.7131/2020

Federico Argüelles Arias, Javier Crespo, Miguel Ángel Calleja Hernández,

Abstract
Introduction: project CONDIFA (“Consenso Digestivo-Farmacia Hospitalaria”) aims to establish lines of agreement between both specialties in order to improve patient care and resource optimization. In this initial work our goal was to collect the views held by both fields on issues pertaining to their mutual cooperation in our country. Material and methods: an online survey was administered to members of the Sociedad Española de Patología Digestiva (SEPD) and Sociedad Española de Farmacia Hospitalaria (SEFH). It comprised 31 questions, and was developed by a task force established by both Societies. Results: the survey was filled out by 241 gastroenterologists and 126 pharmacists. Of these, 55 % were women. A total of 76.8 % of gastroenterologists and 88.1 % of pharmacists answered that relations between both specialties are good/very good, without reaching statistically significant differences. For both groups pharmaceutical expenditure is a priority/annual objective in their department, albeit they do not agree on prescription freedom and industry influence. Biologics committees are considered to be useful by most respondents, and both groups think it appropriate that meetings/sessions be scheduled between both specialties, and that a reference pharmacist be appointed for gastroenterology. Conclusions: this institutional research, driven by SEPD and SEFH, demonstrates that, while cooperation between the gastroenterology and hospital pharmacy departments is close and adequate, some areas remain open to improvement, which will result in better, more effective patient care.
Share Button
New comment
Comments
No comments for this article
References
El Fahimi N, Calleja MA, Ratnayake L, et al. Audit of a multidisciplinary
approach to improve management of community-acquired pneumonia. Eur J Hosp Pharm. 2019; 26(4): 223-225.
Garrido P, Aldaz A, Calleja MÁ, et al.. [Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer]. Rev Esp Patol. 2018; 51(3): 154-159.
Casellas F, Burgos R, Marcos A, et al.. Consensus document on exclusion diets in irritable bowel síndrome (IBS). Rev Esp Enferm Dig. 2018; 110(12): 806-824.
Vivas D, Roldán I, Ferrandis R, et al. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU. Rev Esp Cardiol (Engl Ed). 2018; 71(7): 553-564.
Crespo J, Albillos A, Buti M, et al. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Rev Esp Enferm Dig. 2019; 111(11): 862-873.
Argüelles Arias F, Barreiro-de Acosta M, Hinojosa J. Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONA EII survey. Rev Esp Enferm Dig. 2016; 108(6): 380-1.
Nogueras A, Chinchilla Fernández MI, Martínez F, et al. . Clinical pharmacy services: from
cost-effectiveness analysis to a productivity indicators model. Eur J Hosp Pharm. 2019; 26(4): 242-243.
Shah NB, Jolly JA, Horst SN, et al. Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiative. Am J Health Syst Pharm. 2019; 76(17): 1296-1304.
Argüelles-Arias F, Barreiro-de-Acosta M, Carballo F, et al. Joint position statement by “Sociedad Española de Patología Digestiva” (Spanish Society of Gastroenterology) and “Sociedad Española de Farmacología” (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel disease. Rev Esp Enferm Dig. 2013; 105(1): 37-43.
Argüelles Arias F, Hinojosa Del Val J, Vera Mendoza I. Update of the SEPD
position statement on the use of biosimilars for inflammatory bowel disease. Rev Esp Enferm Dig. 2018; 110(6):407.
SEFH 2017. En: https://www.sefh.es/sefhpdfs/PosicionamientoBiosimilaresSEFH_puntosclaves_Definitivo.pdf
Related articles

Letter

New technique for the endoscopic removal of long foreign bodies

DOI: 10.17235/reed.2023.9398/2022

Editorial

Acute pancreatitis: an opportunity for gastroenterology hospitalists?

DOI: 10.17235/reed.2022.8573/2022

Review

Practical management of primary biliary cholangitis

DOI: 10.17235/reed.2021.8219/2021

Letter

Pneumatosis intestinalis in anorexia nervosa

DOI: 10.17235/reed.2021.8013/2021

Editorial

Reflex testing. A key tool for the elimination of hepatitis C

DOI: 10.17235/reed.2020.7201/2020

Digestive Diseases Image

Gastrointestinal bleeding due to a primary aortoenteric fistula

DOI: 10.17235/reed.2020.6427/2019

Special Article

The current situation of digestive endoscopy units in the Valencian Community

DOI: 10.17235/reed.2019.5676/2018

Editorial

On the centenary of The Spanish Journal of Gastroenterology (REED)

DOI: 10.17235/reed.2017.5427/2017

Review

Quality indicators in colonoscopy. The colonoscopy procedure

DOI: 10.17235/reed.2018.5408/2017

Editorial

Gastroenterology, a historical specialty with a great future

DOI: 10.17235/reed.2017.5193/2017

Special Article

Patient safety under deep sedation for digestive endoscopic procedures

DOI: 10.17235/reed.2016.4572/2016

Original

Practical aspects of high resolution esophageal manometry

DOI: 10.17235/reed.2016.4441/2016

Letter to the Editor

Acute transverse colon volvulus with secondary gastric isquemia. Case report

DOI: 10.17235/reed.2016.4024/2015

Citation tools
Argüelles Arias F, Crespo J, Calleja Hernández M. Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA study. 7131/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 538 visits.
This article has been downloaded 184 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 13/04/2020

Accepted: 06/07/2020

Online First: 07/09/2020

Published: 10/09/2020

Article revision time: 82 days

Article Online First time: 147 days

Article editing time: 150 days


Share
This article has been rated by 5 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology